ALNT Stock Analysis: Allient | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 1.477m USD | 12M Return: 129.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.4M
EPS Trend: -28.3%
Qual. Beats: 0
Rev. Trend: -50.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Allient Inc. (NASDAQ: ALNT) designs, manufactures, and sells precision and specialty motion control components and systems, serving industrial, vehicle, medical, and aerospace and defense end markets across the Americas, Europe, and Asia-Pacific. Its product portfolio spans servo systems, motion controllers, brushless and brush motors, encoders, motor-drives, gear motors, and power quality filters, distributed through direct sales, manufacturers representatives, and distributors.
The company operates within the Industrials sector (GICS Sub-Industry: Electrical Components & Equipment), a segment positioned to benefit from broader trends in industrial automation, factory electrification, and demand for higher precision in medical and aerospace applications. Headquartered in Amherst, New York, Allient was founded in 1939 and rebranded from Allied Motion Technologies to Allient Inc. in August 2023.
- Aerospace and defense segment revenue grows on rising government spending
- Industrial automation demand drives motion control product sales
- M&A strategy expands portfolio and geographic footprint
| Net Income: 23.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.45 > 1.0 |
| NWC/Revenue: 33.88% < 20% (prev 36.97%; Δ -3.10% < -1%) |
| CFO/TA 0.08 > 3% & CFO 48.9m > Net Income 23.8m |
| Net Debt (185.2m) to EBITDA (79.1m): 2.34 < 3 |
| Current Ratio: 3.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.9m) vs 12m ago 1.45% < -2% |
| Gross Margin: 31.21% > 18% (prev 31.21%; Δ -0.00% > 0.5%) |
| Asset Turnover: 96.27% > 50% (prev 87.93%; Δ 8.35% > 0%) |
| Interest Coverage Ratio: 2.37 > 6 (EBIT TTM 53.8m / Interest Expense TTM 22.7m) |
| A: 0.33 (Total Current Assets 259.5m - Total Current Liabilities 69.6m) / Total Assets 577.7m |
| B: 0.35 (Retained Earnings 201.9m / Total Assets 577.7m) |
| C: 0.09 (EBIT TTM 53.8m / Avg Total Assets 582.3m) |
| D: 1.13 (Book Value of Equity 305.9m / Total Liabilities 271.7m) |
| Altman-Z'' = 5.10 = AAA |
| DSRI: 0.96 (Receivables 91.7m/88.1m, Revenue 560.6m/516.1m) |
| GMI: 1.00 (GM 31.21% / 31.21%) |
| AQI: 0.98 (AQ_t 0.41 / AQ_t-1 0.42) |
| SGI: 1.09 (Revenue 560.6m / 516.1m) |
| TATA: -0.04 (NI 23.8m - CFO 48.9m) / TA 577.7m) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 89.75 with a total of 307,259 shares traded. Over the past week, the price has changed by -9.00%, over one month by +3.26%, over three months by +30.50% and over the past year by +129.51%.
Current recommended Stop Loss: 73.20 (which is 18.4% or 2.6 ATR below the current price).
Allient has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy ALNT.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 73.8 | -17.8% |
P/E Trailing = 60.7622
P/E Forward = 34.1297
P/S = 2.6344
P/B = 4.823
Revenue TTM = 560.6m USD
EBIT TTM = 53.8m USD
EBITDA TTM = 79.1m USD
Long Term Debt = 169.8m USD (from longTermDebt, last quarter)
Short Term Debt = 5.63m USD (from shortTermDebt, last quarter)
Debt = 226.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 28.3m
Net Debt = 185.2m USD (calculated: Debt 226.3m - CCE 41.2m)
Enterprise Value = 1.66b USD (1.48b + Debt 226.3m - CCE 41.2m)
Interest Coverage Ratio = 2.37 (Ebit TTM 53.8m / Interest Expense TTM 22.7m)
EV/FCF = 40.71x (Enterprise Value 1.66b / FCF TTM 40.8m)
FCF Yield = 2.46% (FCF TTM 40.8m / Enterprise Value 1.66b)
FCF Margin = 7.28% (FCF TTM 40.8m / Revenue TTM 560.6m)
Net Margin = 4.25% (Net Income TTM 23.8m / Revenue TTM 560.6m)
Gross Margin = 31.21% ((Revenue TTM 560.6m - Cost of Revenue TTM 385.6m) / Revenue TTM)
Gross Margin QoQ = 30.42% (prev 30.20%)
Tobins Q-Ratio = 2.88 (Enterprise Value 1.66b / Total Assets 577.7m)
Interest Expense / Debt = 10.03% (Interest Expense 22.7m / Debt 226.3m)
Taxrate = 23.26% (7.22m / 31.1m)
NOPAT = 41.3m (EBIT 53.8m * (1 - 23.26%))
Current Ratio = 3.73 (Total Current Assets 259.5m / Total Current Liabilities 69.6m)
Debt / Equity = 0.74 (Debt 226.3m / totalStockholderEquity, last quarter 305.9m)
Debt / EBITDA = 2.34 (Net Debt 185.2m / EBITDA 79.1m)
Debt / FCF = 4.54 (Net Debt 185.2m / FCF TTM 40.8m)
Total Stockholder Equity = 297.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.09% (Net Income 23.8m / Total Assets 577.7m)
RoE = 8.01% (Net Income TTM 23.8m / Total Stockholder Equity 297.7m)
RoCE = 11.50% (EBIT 53.8m / Capital Employed (Equity 297.7m + L.T.Debt 169.8m))
RoIC = 8.50% (NOPAT 41.3m / Invested Capital 485.6m)
WACC = 12.11% (E(1.48b)/V(1.70b) * Re(12.79%) + D(226.3m)/V(1.70b) * Rd(10.03%) * (1-Tc(0.23)))
Discount Rate = 12.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 1.00%
[DCF] Terminal Value 64.31% ; FCFF base≈40.0m ; Y1≈41.9m ; Y5≈48.3m
[DCF] Fair Price = 15.68 (EV 451.7m - Net Debt 185.2m = Equity 266.5m / Shares 17.0m; r=12.11% [WACC]; 5y FCF grow 5.14% → 2.50% )
EPS Correlation: -28.32 | EPS CAGR: -5.41% | SUE: -0.37 | # QB: 0
Revenue Correlation: -50.77 | Revenue CAGR: -2.24% | SUE: 0.15 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.61 | Chg30d=-9.64% | Revisions=-62% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.72 | Chg30d=-4.85% | Revisions=-62% | Analysts=5
EPS current Year (2026-12-31): EPS=2.52 | Chg30d=-4.11% | Revisions=-62% | GrowthEPS=+16.4% | GrowthRev=+5.4%
EPS next Year (2027-12-31): EPS=3.10 | Chg30d=-0.18% | Revisions=-12% | GrowthEPS=+22.6% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: -70% (up=2, down=18)